Amneal Pharmaceuticals Securities Settlement
This settlement is closed to new claims. You can still see what it was about and follow the case in court below. Looking for money you can still claim? Browse open settlements →
What happened
Amneal Pharmaceuticals and certain officers and directors allegedly made false and misleading statements in registration statements and prospectus for Amneal common stock issued in connection with the business combination of Amneal Pharmaceuticals and Impax Laboratories. The defendants have settled the securities class action without admitting wrongdoing.
Do you qualify?
Anyone who purchased or otherwise acquired publicly traded Class A common stock of Amneal issued in connection with the business combination between Legacy Amneal and Impax during the period from May 7, 2018 through May 5, 2021, and was damaged thereby. Excluded are defendants, officers, directors, and affiliates of Amneal.
How to file
Claims administration was completed in April 2024. Eligible court-approved claimants who qualified under the Plan of Allocation have received distributions on July 30, 2024 and July 17, 2025, with subsequent distributions on a rolling basis. Contact the claims administrator at 1-866-615-0973 or info@AmnealSecuritiesLitigation.com for more information.
New to class actions?
This summary was generated from public settlement documents and may contain errors. Confirm eligibility, deadlines, and payment terms on the official settlement website before filing. ClaimWatch is not a law firm and this is not legal advice. Filing a claim is free.
More securities settlements
View all →Tattooed Chef Securities Settlement
Tattooed Chef, Inc. faced a securities lawsuit alleging that purchasers of the company's common stock were damaged. The defendant has agreed to settle all claims in the action for $4,750,000 in cash without admitting wrongdoing.
Estée Lauder Securities Settlement
Estée Lauder is settling securities litigation relating to alleged damages to investors who purchased or acquired publicly traded common stock of The Estée Lauder Companies Inc. during the class period. The defendant has not admitted wrongdoing in this settlement.
E-Commerce China Dangdang Securities Settlement
E-Commerce China Dangdang, Inc. was involved in a take-private transaction (merger) that closed on September 20, 2016. Shareholders who held American Depositary Shares during the Class Period claim they were harmed by undisclosed information related to the Company's take-private transaction. The defendant has agreed to settle these securities claims without admitting wrongdoing.
Evolv Technologies Holdings Securities Settlement
Investors purchased publicly traded common stock of Evolv Technologies Holdings Inc. during a specific period and are entitled to compensation from a securities class action settlement. The page does not explicitly state what wrongdoing Evolv allegedly committed.